Healthcare provider profile · identity verified

Terri D. Walton, MD

Internal Medicine · WICHITA, KS · NPI 1447269618

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	925	220
Atorvastatin Calcium	Atorvastatin Calcium	810	221
Losartan Potassium	Losartan Potassium	396	105
Gabapentin	Gabapentin	383	86
Omeprazole	Omeprazole	377	95
Levothyroxine Sodium	Levothyroxine Sodium	374	95
Lisinopril	Lisinopril	327	88
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	297	80
Metformin Hcl	Metformin Hcl	242	65
Metoprolol Succinate	Metoprolol Succinate	234	67
Furosemide	Furosemide	198	54
Pantoprazole Sodium	Pantoprazole Sodium	198	59
Eliquis	Apixaban	194	29
Meloxicam	Meloxicam	190	54
Metoprolol Tartrate	Metoprolol Tartrate	185	43
Potassium Chloride	Potassium Chloride	185	57
Trazodone Hcl	Trazodone Hcl	183	36
Simvastatin	Simvastatin	176	52
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	175	54
Sertraline Hcl	Sertraline Hcl	172	42
Fluticasone Propionate	Fluticasone Propionate	171	52
Ozempic	Semaglutide	160	23
Allopurinol	Allopurinol	145	34
Albuterol Sulfate Hfa	Albuterol Sulfate	141	39
Hydralazine Hcl	Hydralazine Hcl	141	35
Atenolol	Atenolol	117	33
Tramadol Hcl	Tramadol Hcl	117	34
Alendronate Sodium	Alendronate Sodium	112	31
Hydrochlorothiazide	Hydrochlorothiazide	107	29
Tizanidine Hcl	Tizanidine Hcl	102	36
Carvedilol	Carvedilol	101	27
Famotidine	Famotidine	101	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	101	18
Escitalopram Oxalate	Escitalopram Oxalate	94	19
Estradiol	Estradiol	89	20
Clonidine Hcl	Clonidine Hcl	86	25
Cephalexin	Cephalexin	85	36
Glimepiride	Glimepiride	85	23
Buspirone Hcl	Buspirone Hcl	83	16
Rosuvastatin Calcium	Rosuvastatin Calcium	81	23
Pregabalin	Pregabalin	80	19
Spironolactone	Spironolactone	77	17
Jardiance	Empagliflozin	76	14
Prednisone	Prednisone	72	33
Clopidogrel	Clopidogrel Bisulfate	71	21
Pravastatin Sodium	Pravastatin Sodium	71	20
Citalopram Hbr	Citalopram Hydrobromide	68	17
Ibuprofen	Ibuprofen	67	22
Warfarin Sodium	Warfarin Sodium	67	15
Alprazolam	Alprazolam	66	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	64	19
Oxybutynin Chloride	Oxybutynin Chloride	64	14
Chlorthalidone	Chlorthalidone	63	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	63	16
Metformin Hcl Er	Metformin Hcl	63	11
Tamsulosin Hcl	Tamsulosin Hcl	63	19
Zolpidem Tartrate	Zolpidem Tartrate	62	15
Celecoxib	Celecoxib	59	15
Ezetimibe	Ezetimibe	56	16
Synthroid	Levothyroxine Sodium	56	suppressed
Mirtazapine	Mirtazapine	54	12
Montelukast Sodium	Montelukast Sodium	54	12
Amitriptyline Hcl	Amitriptyline Hcl	53	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	53	15
Doxycycline Hyclate	Doxycycline Hyclate	53	43
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	16
Triamcinolone Acetonide	Triamcinolone Acetonide	51	35
Benazepril Hcl	Benazepril Hcl	50	14
Duloxetine Hcl	Duloxetine Hcl	50	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	50	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	13
Fluoxetine Hcl	Fluoxetine Hcl	46	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	45	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	44	suppressed
Lorazepam	Lorazepam	42	suppressed
Ropinirole Hcl	Ropinirole Hcl	42	suppressed
Amoxicillin	Amoxicillin	41	30
Donepezil Hcl	Donepezil Hcl	41	12
Mounjaro	Tirzepatide	41	suppressed
Bupropion Xl	Bupropion Hcl	40	suppressed
Farxiga	Dapagliflozin Propanediol	40	12
Hydroxyzine Hcl	Hydroxyzine Hcl	36	suppressed
Clonazepam	Clonazepam	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	33	suppressed
Doxepin Hcl	Doxepin Hcl	31	suppressed
Fluconazole	Fluconazole	31	12
Januvia	Sitagliptin Phosphate	30	suppressed
Novolog Flexpen	Insulin Aspart	30	suppressed
Lovastatin	Lovastatin	29	suppressed
Nifedipine Er	Nifedipine	29	11
Naproxen	Naproxen	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	12
Baclofen	Baclofen	26	suppressed
Humalog Kwikpen U-100	Insulin Lispro	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Glipizide	Glipizide	25	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Memantine Hcl Er	Memantine Hcl	24	suppressed
Methocarbamol	Methocarbamol	24	suppressed
Nebivolol Hcl	Nebivolol Hcl	24	suppressed
Torsemide	Torsemide	24	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Bumetanide	Bumetanide	23	suppressed
Clobetasol Propionate	Clobetasol Propionate	22	13
Levetiracetam	Levetiracetam	22	suppressed
Nystatin	Nystatin	22	suppressed
Terbinafine Hcl	Terbinafine Hcl	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Valsartan	Valsartan	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	11
Acyclovir	Acyclovir	19	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	11
Bupropion Hcl	Bupropion Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Finasteride	Finasteride	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Methimazole	Methimazole	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Mercaptopurine	Mercaptopurine	13	suppressed
Methylprednisolone	Methylprednisolone	13	12
Potassium Citrate Er	Potassium Citrate	13	suppressed
Topiramate	Topiramate	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Galantamine Er	Galantamine Hbr	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Ramipril	Ramipril	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Gemtesa	Vibegron	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error